PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
2023-03-13
(Press-News.org)

“Selective protection of normal cells may transform therapy of cancer.” 

BUFFALO, NY- March 13, 2023 – A new review paper was published in Oncotarget's Volume 14 on March 11, 2023, entitled, “Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells.”

Cancer therapy is limited by toxicity in normal cells and drug-resistance in cancer cells. In his latest review, Mikhail V. Blagosklonny, M.D., Ph.D., from Roswell Park Comprehensive Cancer Center discusses the theory that cancer resistance to certain therapies can be exploited for protection of normal cells—simultaneously enabling the selective killing of resistant cancer cells by using antagonistic drug combinations, which include cytotoxic and protective drugs. 

“No cancer cell, no matter how resistant it is, can survive chemotherapy in a cell culture. In the organism, however, therapy of cancer is limited by killing or damaging normal cells. Selective protection of normal cells from chemotherapy would increase the therapeutic window, improving the therapeutic outcome. Needless to say, reduction of side effects and better quality of life are very important for a cancer patient.”

Depending on the mechanisms of drug-resistance in cancer cells, the protection of normal cells can be achieved with inhibitors of CDK4/6, caspases, Mdm2, mTOR, and mitogenic kinases. When normal cells are protected, the selectivity and potency of multi-drug combinations can be further enhanced by adding synergistic drugs, in theory, eliminating the deadliest cancer clones with minimal side effects. 

“I also discuss how the recent success of Trilaciclib may foster similar approaches into clinical practice, how to mitigate systemic side effects of chemotherapy in patients with brain tumors and how to ensure that protective drugs would only protect normal cells (not cancer cells) in a particular patient.”

 

Read the full review: DOI: https://doi.org/10.18632/oncotarget.28382 

Correspondence to: Mikhail V. Blagosklonny

Emails: Blagosklonny@oncotarget.com, Blagosklonny@rapalogs.com 

Keywords: oncology, resistance, cyclotherapy, trilaciclib, rapamycin
 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

Twitter  Facebook  YouTube  Instagram  LinkedIn  Pinterest  LabTube Soundcloud

For media inquiries, please contact: media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Str., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

ELSE PRESS RELEASES FROM THIS DATE:

Agriculture needs fresh approach to tackle insect resistance to biopesticides, new analysis finds

Agriculture needs fresh approach to tackle insect resistance to biopesticides, new analysis finds
2023-03-13
Insect pests which attack crops have extraordinary powers to develop resistance to greener pesticides and a new way to manage resistance risks is needed, according to analysis by University of Stirling scientists. For more than 70 years, agriculture’s response to pesticide resistance has been to seek new pesticides in an endless race to keep up with evolving pests. Researchers now propose a new way to step off this treadmill as farmers embrace the ongoing green revolution in pest control by switching to biopesticides derived from natural organisms. The evolution of resistance to biopesticides - a crucial tool in ...

Racial health inequality in prostate cancer associated with facility-level disparities

2023-03-13
Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-level and physician-level factors have been used to explain the racial and socioeconomic differences in prostate cancer disparities. However, a new study led by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigated the role of facilities themselves ...

Scientists develop new concepts about the shape and dynamic nature of molecules

2023-03-13
-With pictures- Scientists have demonstrated in a new study that carbon-based molecules can be much more dynamic than previously thought. When a carbon atom forms four bonds to different groups, the molecule can exist in two mirror image forms. These mirror image forms are vital in medicine because they have different biological activities. Usually, it is impossible to interconvert between these ‘enantiomers’ because to do so would require a bond to be broken, a process that needs too much energy. The researchers ...

Minke whales are as small as a lunge-feeding baleen whale can be

Minke whales are as small as a lunge-feeding baleen whale can be
2023-03-13
A new study of Antarctic minke whales reveals a minimum size limit for whales employing the highly efficient “lunge-feeding” strategy that enabled the blue whale to become the largest animal on Earth. Lunge feeding whales accelerate toward a patch of prey, engulf a huge volume of water, and then filter out the prey through the baleen plates in their mouths. This strategy is used by the largest group of baleen whales, known as rorquals, which includes blue, fin, humpback, and minke whales. The ability ...

UK scientists discover a new way to help prevent breast cancer ‘time bomb’

2023-03-13
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours. Their research, funded by Breast Cancer Now, reveals the mechanism that triggers this breast cancer 'time bomb' – and suggests a strategy to defuse it. Patients with oestrogen receptor positive (ER+) breast cancer – the most common type – have a continued risk of their cancer recurring in another part of their body for many years or even decades after their original ...

The right cocktail of gut enzymes can stop c. diff in its tracks

2023-03-13
Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and by creating a new class of bile acids within the gut's microbial environment. The work could lead to “designer” probiotics that protect against disease by introducing specific BSHs to the gut after antibiotic treatment. Selecting the right suite of BSH-producing bacteria is critical, because the study found that interactions between BSHs and bile acids ...

Researchers identify novel genes that may increase risk for schizophrenia

2023-03-13
New York, NY (March 13, 2023) – Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism. Led by the Icahn School of Medicine at Mount Sinai, the multi-center study further demonstrated that the schizophrenia risk conferred by these rare damaging variants is conserved across ethnicities. The study may also point to new therapeutics. The findings were published in the March 13 online issue of Nature ...

Changing landscapes alter disease-scapes: Study

2023-03-13
A new study has highlighted how and when changes to the environment result in animal-borne disease thresholds being breeched, allowing for a better understanding and increased capacity to predict the risk of transmissions.  For the first time, researchers from Griffith University, Stanford University and the University of California used cumulative pressure mapping and machine learning to better understand how six vector-borne diseases (those transmitted by biting insects) found in different environments responded to the effects of human pressures.  Published in Nature Sustainability, the research found diseases associated with ...

New AI model transforms understanding of metal-organic frameworks

New AI model transforms understanding of metal-organic frameworks
2023-03-13
How does an iPhone predict the next word you’re going to type in your messages? The technology behind this, and also at the core of many AI applications, is called a transformer; a deep-learning algorithm that detects patterns in datasets. Now, researchers at EPFL and KAIST have created a transformer for Metal-Organic Frameworks (MOFs), a class of porous crystalline materials. By combining organic linkers with metal nodes, chemists can synthesize millions of different materials with potential applications in energy storage and gas separation. The “MOFtransformer” is designed to be the ChatGPT for researchers that study MOFs. It’s architecture is based ...

Magnetism fosters unusual electronic order in quantum material

Magnetism fosters unusual electronic order in quantum material
2023-03-13
HOUSTON – (March 13, 2023) – Physicists were surprised by the 2022 discovery that electrons in magnetic iron-germanium crystals could spontaneously and collectively organize their charges into a pattern featuring a standing wave. Magnetism also arises from the collective self-organization of electron spins into ordered patterns, and those patterns rarely coexist with the patterns that produce the standing wave of electrons physicists call a charge density wave. In a study published this week in Nature Physics, Rice University physicists Ming Yi and Pengcheng Dai, and many of their collaborators from the 2022 ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Oncotarget | Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells